FeesSafety
Pluang+

Perp City launches Internet Meltdown market to trade internet security risks on Arbitrum.

Market News
08 Nov 2026, 21:18 WIB
Tokenpost
View Source
Neutral
Perp City launches Internet Meltdown market to trade internet security risks on Arbitrum.

Arbitrum announced the launch of Internet Meltdown on Perp City, a new perpetual market designed for trading internet security risks. This innovative market allows investors to speculate on risks related to internet security, potentially opening new avenues for digital asset trading. The development highlights growing interest in security risk markets within decentralized finance platforms. Investors should watch how this market evolves and impacts the broader digital asset ecosystem.

Arbitrum's launch of the Internet Meltdown perpetual market on Perp City offers new trading opportunities in internet security risks. For readers following cryptocurrency markets, here is Pluang's market snapshot as of Nov 09, 2026 02:21 WIB: out of 50 major cryptocurrencies, 8 rose and 41 fell. Notable movers include FIL at Rp13.839 with a 1-day change of -4.49% and 84% sell order activity, THETA at Rp2.532 with -4.09% and 79% buy order activity, and XTZ at Rp4.584 with -4.00% and 90% sell order activity.

More News

Velinotamig shows strong safety and efficacy in treating refractory systemic lupus erythematosus, with notable kidney improvements.

Velinotamig shows strong safety and efficacy in treating refractory systemic lupus erythematosus, with notable kidney improvements.

Cullinan Therapeutics announced promising Phase 1b/2a trial results for velinotamig, a BCMAxCD3 T cell engager, in patients with refractory moderate-to-severe systemic lupus erythematosus (SLE). Among nine evaluable patients, eight showed significant...

Market News
Bullish
4 hours ago
CRISPR Therapeutics reports positive Phase 1 results for zugo-cel in treating refractory autoimmune diseases.

CRISPR Therapeutics reports positive Phase 1 results for zugo-cel in treating refractory autoimmune diseases.

CRISPR Therapeutics announced encouraging Phase 1 trial results for zugo-cel, their gene-edited CAR-T cell therapy targeting refractory autoimmune diseases like systemic sclerosis, lupus, and idiopathic inflammatory myopathy. Among 21 patients treate...

Market News
Bullish
4 hours ago
Colin Kaepernick named Humanitarian of the Year at 2026 Muhammad Ali Humanitarian Awards.

Colin Kaepernick named Humanitarian of the Year at 2026 Muhammad Ali Humanitarian Awards.

At the 13th annual Muhammad Ali Humanitarian Awards in Louisville, Colin Kaepernick was honored as Humanitarian of the Year for his activism and entrepreneurship, including founding literacy platform Lumi and Know Your Rights Camp. The event also rec...

Others
Neutral
4 hours ago
New Phase 1/2 data show Cabaletta's rese-cel therapy offers durable, immunomodulator-free benefits in autoimmune diseases.

New Phase 1/2 data show Cabaletta's rese-cel therapy offers durable, immunomodulator-free benefits in autoimmune diseases.

Cabaletta Bio announced Phase 1/2 clinical data for rese-cel, a CAR T cell therapy targeting autoimmune diseases, showing durable benefits without immunomodulators across dermatomyositis, lupus nephritis, and systemic sclerosis patients. All dermatom...

Market News
Bullish
4 hours ago
Bitcoin Cash drops 4.5%, deepening weekly losses over 13% as Bitcoin holds steady near $75,800

Bitcoin Cash drops 4.5%, deepening weekly losses over 13% as Bitcoin holds steady near $75,800

Bitcoin Cash (BCH) fell about 4.5% on November 8, extending its weekly losses beyond 13%, while Bitcoin remained stable near $75,800. BCH's price dropped below key support levels around $250 and tested $244, signaling weaker demand compared to Bitcoi...

Bearish
5 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App